United Drug PLCUDG:LSE

Add to portfolio
Set alert
Interactive chart
Historical prices
Data definitions
329.00
1.100 / 0.33%
270.47k
81.27%
1.21
Close in GBXToday's changeShares traded1 year changeBeta
As of May 17 2013 16:50 BST.Data delayed by at least 15 minutes.

Interactive chart

Summary

On Friday, United Drug PLC (UDG:LSE) closed at 329.00, 3.24% below its 52-week high of 340.00, set on May 09, 2013.

52-week range
Today
158.50
Jul 06 2012
340.00
May 09 2013
Markit short selling activity
Low
Medium
High
What is this
Open329.40
Day high330.80
Day low325.00
Bid328.10
Offer329.00
Previous close330.10
Average volume319.57k
Shares outstanding240.20m
Free float191.47m
P/E (TTM)19.61
Market cap792.76m GBP
EPS (TTM)0.1683 GBP
Annual div (TTM)7.76 EUc
Annual div yield (TTM)2.36%
Div ex-dateMay 15 2013
Div pay-dateJul 16 2013

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
United Drug PLC+1.20%+10.29%+42.42%+81.27%+5.28%
FTSE 100 Index+1.48%+7.67%+19.93%+25.94%+6.64%
GB/HEALTH CARE+1.98%+2.96%+20.58%+18.78%--
WRLD/H CARE PROV & SVC+0.33%+6.57%+19.06%+21.08%+36.53%
As of May 17 2013 16:50 BST.Data delayed by at least 15 minutes.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.